Repositorio Dspace

Lifetime use of psychedelics is associated with better mental health indicators during the COVID-19 pandemic

Mostrar el registro sencillo del ítem

dc.contributor.author Cavanna, Federico
dc.contributor.author Pallavicini, Carla
dc.contributor.author Milano, Virginia
dc.contributor.author Cuiule, Juan Manuel
dc.contributor.author Di Tella, Rocco
dc.contributor.author González, Pablo
dc.contributor.author Tagliazucchi, Enzo
dc.date.accessioned 2021-05-17T14:41:06Z
dc.date.available 2021-05-17T14:41:06Z
dc.date.issued 2021-05-04
dc.identifier.citation Cavanna, F., Pallavicini, C., Milano, V., Cuiule, J., Tella, R.D., González, P., Tagliazucchi, E., 2021. Lifetime use of psychedelics is associated with better mental health indicators during the COVID-19 pandemic. Journal of Psychedelic Studies 1. https://doi.org/10.1556/2054.2021.00172 es_ES
dc.identifier.uri https://doi.org/10.1556/2054.2021.00172
dc.identifier.uri https://repositorio.fleni.org.ar/xmlui/handle/123456789/486
dc.description.abstract Background and aims: The COVID-19 pandemic and its consequences represent a major challenge to the mental health and well-being of the general population. Building on previous work on the potential long-term benefits of psychedelics, we hypothesized that lifetime use of these drugs could be linked to better mental health indicators in the context of the ongoing pandemic. Methods: Two anonymous online surveys were conducted between April and June 2020, including questions about lifetime experience with psychedelics and other psychoactive drugs, and psychometric scales designed to measure personality traits, anxiety, negative, and positive affect, well-being, and resilience. Principal component analysis was applied to divide the sample into groups of subjects based on their drug use reports. Results: Five thousand six hundred eighteen participants (29.15 ± 0.12 years, 71.97% female) completed both surveys and met the inclusion criteria, with 32.43% of the sample reporting at least one use of a psychedelic drug. Preliminary analyses showed that certain psychedelics were linked to improved mental health indicators, while other psychoactive drugs exhibited the opposite behavior. Lifetime psychedelic use was linked to increased openness and decreased conscientiousness, and to higher scores of positive affect. The reported number of past psychedelic experiences predicted higher scores of the secondary personality trait beta factor, which has been interpreted as a measure of plasticity. No significant associations between lifetime use of psychedelics and indicators of impaired mental health were observed. Conclusion: We did not find evidence of an association between lifetime use of psychedelics and poor mental health indicators. Conversely, experience with psychedelic drugs was linked to increased positive affect and to personality traits that favor resilience and stability in the light of the ongoing crisis. es_ES
dc.language.iso eng es_ES
dc.publisher Akadémiai Kiadó es_ES
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by/2.5/ar/
dc.subject Hallucinogens es_ES
dc.subject Alucinógenos es_ES
dc.subject Mental Health es_ES
dc.subject Salud Mental es_ES
dc.subject Resilience, Psychological es_ES
dc.subject Resiliencia Psicológica es_ES
dc.subject COVID-19 es_ES
dc.subject Psychotropic Drugs es_ES
dc.subject Psicotrópicos es_ES
dc.title Lifetime use of psychedelics is associated with better mental health indicators during the COVID-19 pandemic es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.type info:eu-repo/semantics/publishedVersion
dc.description.fil Fil: Cavanna, Federico. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Física. Instituto de Física de Buenos Aires; Argentina. Fleni. Instituto de Neurociencias FLENI-CONICET; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina.
dc.description.fil Fil: Pallavicini, Carla. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Física. Instituto de Física de Buenos Aires; Argentina. Fleni. Instituto de Neurociencias FLENI-CONICET; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina.
dc.description.fil Fil: Milano, Virginia. El Gato y La Caja; Argentina.
dc.description.fil Fil: Cuiule, Juan. El Gato y La Caja; Argentina.
dc.description.fil Fil: Di Tella, Rocco. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Física. Instituto de Física de Buenos Aires; Argentina. El Gato y La Caja; Argentina.
dc.description.fil Fil: González, Pablo. El Gato y La Caja; Argentina.
dc.description.fil Fil: Tagliazucchi, Enzo. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Física. Instituto de Física de Buenos Aires; Argentina. Universidad Adolfo Ibanez; Chile.
dc.relation.ispartofCOUNTRY Hungría
dc.relation.ispartofCITY Budapest
dc.relation.ispartofTITLE Journal of Psychedelic Studies
dc.relation.ispartofISSN 2559-9283
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/openAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/openAccess

Buscar en DSpace


Listar

Mi cuenta

Estadísticas